Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer. [electronic resource]
Producer: 19970127Description: 2008-12 p. digitalISSN:- 0007-0920
- Adult
- Antibiotics, Antineoplastic -- administration & dosage
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Neoplasms -- secondary
- Brain Neoplasms -- secondary
- Breast Neoplasms -- drug therapy
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Humans
- Infusions, Intravenous
- Injections, Intravenous
- Liver Neoplasms -- secondary
- Lung Neoplasms -- secondary
- Lymphatic Metastasis
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.